Learn / TRAX
NASDAQ: TRAX
First Tracks Biotherapeutics (TRAX) stock, explained like you're 5
First Tracks Biotherapeutics trades on the Nasdaq under the ticker TRAX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.
- Ticker
- TRAX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.1 billion dollars
Is First Tracks Biotherapeutics a small, medium or large cap company?
No. First Tracks Biotherapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How First Tracks Biotherapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves TRAX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- TRAX Stock Hits All Time High What's Driving The Super Rally? (Stocktwits)
- First Tracks Biotherapeutics (TRAX) Stock Looks Rich Following Phase 1b Celiac Data (Yahoo Finance)
- First Tracks Biotherapeutics (TRAX) Stock Looks Stretched Following Its 67% Run (Simply Wall Street)
- First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rating Raised to "Hold" at Wall Street Zen (MarketBeat)
- Why Is First Tracks Biotherapeutics Stock Soaring Monday? (Benzinga)
Follow TRAX in your daily brief
Each trading day at 5 PM ET we post what happened to First Tracks Biotherapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow TRAX
Questions about First Tracks Biotherapeutics stock
What does First Tracks Biotherapeutics do?
First Tracks Biotherapeutics trades on the Nasdaq under the ticker TRAX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.1 billion dollars.
What is the ticker symbol for First Tracks Biotherapeutics?
First Tracks Biotherapeutics trades under the ticker TRAX on the Nasdaq.
What is First Tracks Biotherapeutics's market cap?
First Tracks Biotherapeutics is a small cap stock with a market cap of about 1.1 billion dollars.
How does First Tracks Biotherapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves TRAX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow TRAX stock every day?
Add TRAX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.